Stintzing, S; Hubner, G; Schroder, J; Kisro, J; Welslau, M; Burkle, D; Gohler, T; Schmidt, B; Muller-Huesmann, H; Krammer-Steiner, B; von der Heyde, E; Reichenbach, F; Arnold, D; Gerger, A; Hegewisch-Becker, S; Vogel, A; Winder, T; Prager, G.
Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: A multi-centric, multi-national, prospective, longitudinal, non-interventional study in Germany and Austria - BERING CRC
ANN ONCOL. 2021; 32: S116-S116.
Doi: 10.1016/j.annonc.2021.05.113
[Poster]
Web of Science
FullText
FullText_MUG